• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TEPF:GR

18.4600 EUR 0.1900 1.04%

As of 15:45:03 ET on 07/11/2014.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TEPF)

Open: 18.4400 High - Low: 18.5600 - 18.3800 Primary Exchange: Stuttgart
Volume: 70 52-Week Range: 14.5900 - 21.5100 Beta vs NBI: 0.9275

ETF Chart for TEPF

No chart data available.
  • TEPF:GR 18.4400
  • 1D
  • 1M
  • 1Y
18.2700
Interactive TEPF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TEPF

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: 2000-04-03 Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH
Web Site: www.franklintempleton.lu

Fundamentals for TEPF

NAV -
Assets (M) (on 2014-05-31) 2,981.2010
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for TEPF

No dividends reported

Performance for TEPF

1-Month +2.10% 1-Year +21.53%
3-Month +14.52% 3-Year +30.53%
Year To Date +10.14% 5-Year +27.14%
Expense Ratio 1.82

Top Fund Holdings for TEPF

Filing Date: 04/30/2014
Name Position Value % of Total
Gilead Sciences Inc 4,065,000 319,061,850 10.929%
Biogen Idec Inc 774,540 222,385,925 7.618%
Amgen Inc 1,357,100 151,655,925 5.195%
Celgene Corp 2,005,000 147,377,525 5.048%
Regeneron Pharmaceuticals Inc 492,000 146,069,880 5.003%
Medivation Inc 2,116,100 127,410,381 4.364%
Alexion Pharmaceuticals Inc 567,200 89,731,040 3.074%
Incyte Corp Ltd 1,741,200 84,552,672 2.896%
Illumina Inc 606,400 82,379,440 2.822%
Vertex Pharmaceuticals Inc 1,018,100 68,925,370 2.361%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil